{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:47:32Z","timestamp":1781880452701,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cyto.2024.156735","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:49:16Z","timestamp":1724370556000},"page":"156735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Correlation between inflammatory cytokines and the likelihood of developing multiple types of digestive system cancers: A Mendelian randomization study"],"prefix":"10.1016","volume":"183","author":[{"given":"Su-Lan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2024.156735_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cyto.2024.156735_b0015","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/DDDT.S308578","article-title":"Clinical application of cytokines in cancer immunotherapy","volume":"15","author":"Qiu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cyto.2024.156735_b0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/bs.apcsb.2019.09.004","article-title":"Interplay between inflammation and cancer. Inflammatory disorders, Part A","author":"Khandia","year":"2020","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02736-7","article-title":"Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.cyto.2024.156735_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10360","key":"10.1016\/j.cyto.2024.156735_b0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"10060","key":"10.1016\/j.cyto.2024.156735_b0045","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0140-6736(16)30354-3","article-title":"Gastric cancer","volume":"388","author":"Van Cutsem","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cyto.2024.156735_b0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review [published correction appears in JAMA. 2021 Nov 23;326(20):2081. doi: 10.1001\/jama.2021.19984]","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"10449","key":"10.1016\/j.cyto.2024.156735_b0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2013.08.025","article-title":"Inflammation and gastrointestinal cancer: an overview","volume":"345","author":"Marusawa","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cyto.2024.156735_b0065","article-title":"Targeted immunotherapies in gastrointestinal cancer: from molecular mechanisms to implications","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156735_b0070","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40880-019-0427-z","article-title":"The immune landscape of esophageal cancer","volume":"39","author":"Huang","year":"2019","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.cyto.2024.156735_b0085","first-page":"762","article-title":"Expression of CD80, CD86, TGF-beta1 and IL-10 mRNA in the esophageal carcinoma","volume":"28","author":"Yang","year":"2006","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/XCS.0000000000000446","article-title":"Role of IL4 and GMCSF in predicting survival in esophageal cancer","volume":"236","author":"Rebernick","year":"2022","journal-title":"J. Am. Coll. Surg."},{"issue":"7","key":"10.1016\/j.cyto.2024.156735_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071997","article-title":"Interleukin-8 and interleukin-6 are biomarkers of poor prognosis in esophageal squamous cell carcinoma","volume":"15","author":"Pastrez","year":"2023","journal-title":"Cancers"},{"issue":"29","key":"10.1016\/j.cyto.2024.156735_b0100","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1038\/s41388-018-0246-8","article-title":"Tocopherols inhibit esophageal carcinogenesis through attenuating NF-\u03baB activation and CXCR3-mediated inflammation","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbrc.2018.04.094","article-title":"MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cyto.2024.156735_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975986","article-title":"Immunotherapy resistance in esophageal cancer: possible mechanisms and clinical implications","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156735_b0115","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s00262-023-03566-5","article-title":"Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"13","key":"10.1016\/j.cyto.2024.156735_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137191","article-title":"Inflammatory response in the pathogenesis and treatment of hepatocellular carcinoma: a double-edged weapon","volume":"25","author":"Galasso","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2024.156735_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-017-3092-z","article-title":"Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma","volume":"437","author":"Rai","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cyto.2024.156735_b0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.biopha.2018.12.004","article-title":"Insight into the role of TRAIL in liver diseases","volume":"110","author":"Jiang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.cyto.2024.156735_b0135","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1074\/jbc.M806268200","article-title":"Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2024.156735_b0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.omto.2021.04.004","article-title":"Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer","volume":"21","author":"Vaughan","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"3","key":"10.1016\/j.cyto.2024.156735_b0145","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/hep.29513","article-title":"A multifunctional nanocarrier for efficient TRAIL-based gene therapy against hepatocellular carcinoma with desmoplasia in mice","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0150","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3892\/ijo.2016.3751","article-title":"Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN\/PI3K\/Akt\/Bad signaling pathway","volume":"49","author":"Feng","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"13","key":"10.1016\/j.cyto.2024.156735_b0155","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.7150\/thno.19893","article-title":"Combination of AAV-TRAIL with miR-221-Zip therapeutic strategy overcomes the resistance to TRAIL induced apoptosis in liver cancer","volume":"7","author":"Ma","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0160","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5206","article-title":"Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)","volume":"51","author":"Thapa","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cyto.2024.156735_b0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/CMAR.S183328","article-title":"<p>Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing PI3K\/Akt\/Bad cascade via regulating PTEN<\/p>","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.cyto.2024.156735_b0170","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1006\/mthe.2001.0477","article-title":"Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor","volume":"4","author":"Dan","year":"2001","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.cyto.2024.156735_b0175","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-16-0866","article-title":"Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma","volume":"16","author":"Ao","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cyto.2024.156735_b0180","first-page":"8","article-title":"Ultrasound molecular imaging as a potential non-invasive diagnosis to detect the margin of hepatocarcinoma via CSF-1R targeting","author":"Jiang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156735_b0185","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/hepr.12174","article-title":"Macrophage colony-stimulating factor plays a pivotal role in chemically induced hepatocellular carcinoma in mice","volume":"44","author":"Hara","year":"2013","journal-title":"Hepatol. Res."},{"issue":"9","key":"10.1016\/j.cyto.2024.156735_b0190","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","article-title":"Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade","volume":"68","author":"Zhu","year":"2019","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.cyto.2024.156735_b0195","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11033-009-9469-7","article-title":"Interleukin-18 gene promoter and serum level in women with ovarian cancer","volume":"36","author":"Samsami Dehaghani","year":"2009","journal-title":"Mol. Biol. Rep."},{"issue":"10","key":"10.1016\/j.cyto.2024.156735_b0200","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.17219\/acem\/126298","article-title":"Anti-cancer effect of engineered recombinant interleukin 18","volume":"29","author":"Saetang","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.cyto.2024.156735_b0205","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41422-020-00396-3","article-title":"IL-18: throwing off the shackles to boost anti-tumor immunity","volume":"30","author":"Dixon","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajg.2010.11.002","article-title":"Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?","volume":"12","author":"Mohran","year":"2011","journal-title":"Arab J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcp.24441","article-title":"Regulation of cellular processes by interleukin-16 in homeostasis and cancer","volume":"229","author":"Richmond","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0220","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.3892\/mmr.2017.7688","article-title":"Diagnostic and prognostic value of serum interleukin-16 in patients with gastric cancer","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.cyto.2024.156735_b0225","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.7314\/APJCP.2013.14.9.5269","article-title":"Variants of interleukin-16 associated with gastric cancer risk","volume":"14","author":"Zhang","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.cyto.2024.156735_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102752","article-title":"The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer","volume":"15","author":"Pimentel","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0235","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.21037\/jgo-22-928","article-title":"Decitabine enhances the tumoricidal potential of TRAIL via the epigenetic regulation of death receptor 4 in gastric cancer","volume":"13","author":"Li","year":"2022","journal-title":"J. Gastroint. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156735_b0240","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.7150\/ijms.34398","article-title":"Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL","volume":"16","author":"Bui","year":"2019","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0245","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mc.22991","article-title":"Antitumor Effect of Periplocin in TRAIL-resistant gastric cancer cells via upregulation of death receptor through activating ERK1\/2-EGR1 pathway","volume":"58","author":"Zhao","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cyto.2024.156735_b0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2021.01.006","article-title":"5-Fluorouracil enhances the chemosensitivity of gastric cancer to TRAIL via inhibition of the MAPK pathway","volume":"540","author":"Li","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.cyto.2024.156735_b0255","article-title":"GSK-3 inhibitors enhance TRAIL-mediated apoptosis in human gastric adenocarcinoma cells","volume":"13","author":"Hsieh","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cyto.2024.156735_b0260","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00262-024-03632-6","article-title":"Clinical immunotherapy in pancreatic cancer","volume":"73","author":"Ye","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2013.07.014","article-title":"Inflammatory cytokines in human pancreatic cancer","volume":"345","author":"Roshani","year":"2014","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.cyto.2024.156735_b0270","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/01.LAB.0000036875.21209.F9","article-title":"The stem cell factor-c-kit system and mast cells in human pancreatic cancer","volume":"82","author":"Esposito","year":"2002","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0275","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.2005.024","article-title":"Hematopoietic cytokines in the sera of patients with pancreatic cancer","volume":"43","author":"Mroczko","year":"2005","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"3","key":"10.1016\/j.cyto.2024.156735_b0280","article-title":"SCF, Regulated by HIF-1\u03b1, promotes pancreatic ductal adenocarcinoma cell progression","volume":"10","author":"Batra","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2024.156735_b0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.cyto.2024.156735_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225359","article-title":"Colorectal liver metastasis: can cytokines make the difference?","volume":"15","author":"Ballar\u00f2","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/medicina55060262","article-title":"Local and systemic IL-7 concentration in gastrointestinal-tract cancers","volume":"55","author":"Bednarz-Misa","year":"2019","journal-title":"Medicina"},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0300","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.rpor.2020.08.004","article-title":"Serum cytokine profile as a potential prognostic tool in colorectal cancer patients \u2013 one center study","volume":"25","author":"Czajka-Francuz","year":"2020","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00262-016-1933-3","article-title":"Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon","volume":"66","author":"Krzystek-Korpacka","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cyto.2024.156735_b0310","first-page":"87","article-title":"IL-7 and IL-7R in health and disease: an update through COVID times","author":"Fernandes","year":"2023","journal-title":"Adv. Biol. Regul."},{"issue":"3","key":"10.1016\/j.cyto.2024.156735_b0315","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3892\/etm.2015.2588","article-title":"Association between low expression levels of interleukin-9 and colon cancer progression","volume":"10","author":"Huang","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cyto.2024.156735_b0320","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2021.01.002","article-title":"ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells","volume":"502","author":"Wan","year":"2021","journal-title":"Cancer Lett."},{"issue":"7918","key":"10.1016\/j.cyto.2024.156735_b0325","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-022-04801-2","article-title":"Potentiating adoptive cell therapy using synthetic IL-9 receptors","volume":"607","author":"Kalbasi","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cyto.2024.156735_b0330","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41590-018-0297-6","article-title":"IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3","volume":"20","author":"Zhu","year":"2019","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156735_b0335","article-title":"Interleukin 13 receptor alpha 2 (IL13R\u03b12): expression, signaling pathways and therapeutic applications in cancer","volume":"1877","author":"Ja\u00e9n","year":"2022","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Rev. Cancer"},{"key":"10.1016\/j.cyto.2024.156735_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878365","article-title":"Recent advances in IL-13R\u03b12-directed cancer immunotherapy","volume":"13","author":"Knudson","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156735_b0345","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2326-6066.CIR-19-0360","article-title":"Anti-VEGF treatment enhances CD8+ T-cell antitumor activity by amplifying hypoxia","volume":"8","author":"de Almeida","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.cyto.2024.156735_b0350","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.30567","article-title":"Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer","volume":"140","author":"Canavese","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.cyto.2024.156735_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041232","article-title":"Resistance to anti-angiogenic therapy in cancer\u2014alterations to anti-VEGF pathway","volume":"19","author":"Itatani","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:55:52Z","timestamp":1727121352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":71,"alternative-id":["S1043466624002382"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156735","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between inflammatory cytokines and the likelihood of developing multiple types of digestive system cancers: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156735"}}